In patients with osteogenesis imperfecta, osteoblasts exhibit decreased levels of osteonectin [105], and a mutation in the osteonectin gene was found to lead to a severe form of osteogenesis imperfecta [106]. This evidence concerns the gene SPARC and osteogenesis imperfecta.